Scholar Rock Holding Corporation (SRRK)

NASDAQ • Healthcare

$46.81

+$0.65 (+1.4%)

Market closed

Last close at October 2, 2026 at 20:00 UTC

Open$46.74

Day Range$46.08 - $47.8

Avg. Volume (3M)2.3M

Market Cap$5.6B

52 Week Range

$27.07$61.76

Next EarningsIn 40 daysNov 13, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)

Net Income (TTM)

-$408.5M

EPS (TTM)

-$3.31

ROA (TTM)

-78.04%

Current Ratio

7.02

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-48.5%Q3 2025-$0.98

-7.8%Q4 2025-$0.9

+0.3%Q1 2026-$0.88

-1.2%Q2 2026-$0.83

+0.1%Q3 2026-$0.84

Nov 13

in 40 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +0.1%

Based on preliminary results reported August 6, 2026, Scholar Rock’s net loss in the second fiscal quarter of 2026 was essentially unchanged year over year, with net income up +0.1% to roughly -$109.9 million versus about -$110.0 million a year ago. EPS came in at -$0.84, improving +14.3% from -$0.98 in the prior-year period. Operating income was roughly -$108.9 million, and the company generated negative operating cash flow of about -$69.6 million during the quarter. For the next period, consensus calls for EPS of USD -0.87 on revenue of USD 75,000.00.

View full earnings history

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation develops targeted therapies that modulate protein growth factor signaling as a NASDAQ-listed biotechnology company. The company focuses on precision inhibitors of transforming growth factor beta, or TGF-beta, activation and advances programs in neuromuscular disease, cancer, and fibrotic disease research.

Name

Scholar Rock Holding Corporation

CEO

David L. Hallal

Website

scholarrock.com

Industry

Healthcare

Year Founded

2012

Employees

289

Today's Snapshot

AI-generated

SRRK closed 1.4% higher at 46.81, while its sector was flat. Trading was lighter than usual, with volume about two-thirds of its usual level.

Trading Volume

Below 10d avg (1.9M)

1.2M

vs S&P 500 Today

Outperforming Market

+0.63%

Updated: October 2, 2026 at 20:18 UTC

Technical Indicators

1 Buy1 Neutral6 Sell

SRRK shows a decidedly bearish stance as the price sits below most short and intermediate moving averages, and momentum measures are skewed negative with MACD below zero despite some oversold stochastic readings. ADX around the mid-20s points to a strengthening downtrend, volatility is elevated (ATR over 5%), and OBV is negative, indicating selling on volume. Pivots are close but not supportive, so overall breadth and price structure favor the downside. Technical takeaway: Strong Sell.

All signals